Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Infected Blood Cells' Electrical Properties Indicate Early Malaria

By LabMedica International staff writers
Posted on 27 Aug 2013
A new prototype device recognizes electrical properties of Plasmodium falciparum-infected cells as signatures of disease.

Scientists examined whether it was possible to use electrical impedance as a diagnostic signal for malaria. More...
Several types of infection, including malaria, alter a cell’s impedance, a measure of electrical resistance across the cell membrane. Previous studies had demonstrated electrical changes in later-stage infected cells, but it was not clear that cells that had reached only the ring stage of infection would exhibit electrical changes.

A microfluidic device was constructed that takes a drop of blood and streams it across an electrode that measures a signal differentiating infected cells from uninfected cells. The work, which recognizes ring-stage Plasmodium falciparum infected blood cells, was published August 8, 2003, in the journal Lab On A Chip, could be the first step toward a field-ready, low-cost, portable malaria-detection device.

The microfluidic device built by the scientists was capable of measuring the magnitude and phase of the electrical impedance of individual cells. The device is essentially a cell-counting device, similar in approach to other low-cost, portable devices being developed to diagnose illnesses such as HIV.

“Ultimately the goal would be to create a postage stamp-sized device with integrated electronics that can detect if a person has malaria and at what stage,” said Anantha Chandrakasan, the Joseph F. and Nancy P. Keithley professor of electrical engineering and a principal investigator at Massachusetts Institute of Technology's (MIT; Cambridge, MA, USA) Microsystems Technology Laboratories (MTL) who specializes in developing low-power electronic devices. Similar diagnostics may be applicable to other infections and diseases.

In tests of cells of four cell types—uninfected cells and infected cells at the ring stage, trophozoite, and schizont stages—the device detected small differences in measures of magnitude and seemingly random differences in phase, but not quite enough to definitively differentiate among stages.

However, by mathematically combining the measures into an index called delta, the differences between uninfected cells and all three stages became clear. “It’s much more significant,” said corresponding author Ming Dao, a principal research scientist in the Nanomechanics Laboratory. “It’s a more holistic approach. By using all of the information we can measure, we can detect the differentiating signals much more clearly.”

Malaria is a curable disease, but diagnosis remains a challenge. This ability to discern the circulating parasite’s stage from a drop of blood opens the possibility of building a device that could be used to rapidly diagnose malarial infection in places where laboratories and skilled medical personnel are scarce.

Related Links:

Massachusetts Institute of Technology's
Microsystems Technology Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.